Get the Stockscreener App
4.52
0.00%
0.00
After Hours:
4.73
0.21
+4.65%
Nkarta Inc stock is traded at $4.52, with a volume of 510.52K.
It is up +0.00% in the last 24 hours and down -14.88% over the past month.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
See More
Previous Close:
$4.52
Open:
$4.63
24h Volume:
510.52K
Relative Volume:
0.78
Market Cap:
$322.45M
Revenue:
-
Net Income/Loss:
$-117.50M
P/E Ratio:
-1.7656
EPS:
-2.56
Net Cash Flow:
$-114.31M
1W Performance:
-7.00%
1M Performance:
-14.88%
6M Performance:
-58.19%
1Y Performance:
+225.18%
1-Day Range:
$4.46
$4.76
1-Week Range:
$4.40
$4.94
52-Week Range:
$1.28
$16.24
Nkarta Inc Stock (NKTX) Company Profile
Name
Nkarta Inc
Sector
Industry
Phone
(925) 407-1049
Address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-10-22 | Initiated | Canaccord Genuity | Buy |
| Jul-28-22 | Initiated | Needham | Buy |
| Jul-18-22 | Initiated | SVB Leerink | Outperform |
| Mar-11-22 | Initiated | Raymond James | Outperform |
| Mar-08-22 | Initiated | H.C. Wainwright | Buy |
| Jan-06-22 | Initiated | William Blair | Outperform |
| Nov-18-21 | Initiated | SMBC Nikko | Outperform |
| Jul-16-21 | Initiated | Oppenheimer | Outperform |
| Aug-04-20 | Initiated | Cowen | Outperform |
| Aug-04-20 | Initiated | Evercore ISI | Outperform |
| Aug-04-20 | Initiated | Mizuho | Buy |
| Aug-04-20 | Initiated | Stifel | Buy |
View All
Nkarta Inc Stock (NKTX) Latest News
Nkarta's SWOT analysis: NK cell therapy stock shows promise amid risks - Investing.com UK
Forefront Analytics LLC Invests $70,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Renaissance Technologies LLC Acquires 98,000 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta Inc [NASDAQ: NKTX] Sees Decrease in Stock Value - Knox Daily
Deerfield Management Company L.P. Series C Has $22.45 Million Holdings in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Nkarta upgraded at Raymond James on valuation - MSN
Rhumbline Advisers Acquires 33,117 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Affinity Asset Advisors LLC Purchases New Shares in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Affinity Asset Advisors LLC Takes Position in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Wall Street analysts’ outlook for Nkarta Inc (NKTX) - SETE News
Nkarta Inc (NKTX)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Market Momentum Report: Nkarta Inc (NKTX)’s Negative Close at 5.21 - The Dwinnex
Raymond James Upgrades Nkarta Inc (NKTX) to a Strong buy from an Outperform - Knox Daily
Federated Hermes Inc. Grows Holdings in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Federated Hermes Inc. Boosts Stock Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Infosys Limited (INFY) and Posti Extend Strategic Collaboration - StreetInsider.com
Infosys and Posti Extend Strategic Collaboration – Company Announcement - Financial Times
NKT (CPH:NKT) shareholder returns have been enviable, earning 573% in 5 years - Simply Wall St
Analytical Overview: Nektar Therapeutics (NKTR)’s Ratios Tell a Financial Story - The Dwinnex
Nektar Therapeutics (NKTR) looking to reclaim success with recent performance - SETE News
Quest Partners LLC Makes New $88,000 Investment in NextNav Inc. (NASDAQ:NN) - Defense World
Nektar Therapeutics (NKTR) deserves deeper analysis - US Post News
Quest Partners LLC Sells 3,065 Shares of Napco Security Technologies, Inc. (NASDAQ:NSSC) - Defense World
All Your Questions About Nara Smith & Lucky Blue's Relationship, Answered - ELLE Australia
Nureca shares surge 6% after company signs distribution agreement - Business Upturn
Nektar Therapeutics’s latest rating changes from various analysts - Knox Daily
Is Nkarta Inc (NKTX) a opportunity to investors? - US Post News
Meeder Asset Management Inc. Purchases New Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
(NKTX) Trading Signals - Stock Traders Daily
Acadian Asset Management LLC Grows Holdings in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Acadian Asset Management LLC Has $1.79 Million Stake in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Newell Brands Inc. (NASDAQ:NWL) Shares Bought by Arizona State Retirement System - Defense World
Nkarta Inc [NKTX] stock for 27,168 USD was sold by Hager Alicia J. - Knox Daily
Content sharing startup Newzo Mobile App gets seed funding by Concept PR Mumbai - afaqs!
Nkarta Inc (NKTX) presents a great opportunity, but the stock is slightly overvalued - US Post News
Nkarta Inc Inc. (NKTX) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
Taking a Closer Look At Nkarta Inc (NKTX) Following Its Recent Trade - Knox Daily
We're Hopeful That Nkarta (NASDAQ:NKTX) Will Use Its Cash Wisely - Simply Wall St
Nkarta (NASDAQ:NKTX) Stock Price Down 2% - MarketBeat
Nkarta (NASDAQ:NKTX) Stock Price Down 2% - Defense World
Nkarta Inc [NASDAQ: NKTX] Sees Increase in Stock Value - Knox Daily
Nkarta Inc (NKTX) stock on the rise: An overview - US Post News
Nkarta to Participate in Upcoming Investor Conference - GlobeNewswire
Nkarta to Participate in Upcoming Investor Conference - StockTitan
Analyzing Nkarta Inc (NKTX) After Recent Trading Activity - Knox Daily
Was there any good news for Nkarta Inc (NKTX) stock in the last session? - US Post News
Nkarta Inc [NKTX] Investment Appeal on the Rise - Knox Daily
Prepare Yourself for Liftoff: Nkarta Inc (NKTX) - SETE News
NKTX stock rated a Strong buy by Raymond James - Knox Daily
Mizuho cuts Nkarta stock target, maintains outperform on success rate change - Investing.com
Nkarta Inc (NKTX)’s stock rises to 5.07 per share - US Post News
Nkarta Inc Stock (NKTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):